0001235802-18-000019.txt : 20180301
0001235802-18-000019.hdr.sgml : 20180301
20180301131811
ACCESSION NUMBER: 0001235802-18-000019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180228
FILED AS OF DATE: 20180301
DATE AS OF CHANGE: 20180301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farley Brian E
CENTRAL INDEX KEY: 0001306117
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36814
FILM NUMBER: 18655877
MAIL ADDRESS:
STREET 1: 2200 ZANKER ROAD
STREET 2: SUITE F
CITY: SAN JOSE
STATE: CA
ZIP: 95131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENTELLUS MEDICAL INC
CENTRAL INDEX KEY: 0001374128
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204627978
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3600 HOLLY LANE NORTH
STREET 2: SUITE 40
CITY: PLYMOUTH
STATE: MN
ZIP: 55447
BUSINESS PHONE: 763-463-1595
MAIL ADDRESS:
STREET 1: 3600 HOLLY LANE NORTH
STREET 2: SUITE 40
CITY: PLYMOUTH
STATE: MN
ZIP: 55447
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-02-28
1
0001374128
ENTELLUS MEDICAL INC
ENTL
0001306117
Farley Brian E
3600 HOLLY LANE NORTH, SUITE 40
PLYMOUTH
MN
55447
1
0
0
0
Common Stock, $0.001 par value
2018-02-28
4
D
0
291743
24
D
0
D
Stock Option (right to buy)
1.36
2018-02-28
4
D
0
39563
22.64
D
2020-03-24
Common Stock
39563
0
D
Stock Option (right to buy)
0.76
2018-02-28
4
D
0
28439
23.24
D
2022-02-08
Common Stock
28439
0
D
Stock Option (right to buy)
1.24
2018-02-28
4
D
0
34510
22.76
D
2023-03-19
Common Stock
34510
0
D
Stock Option (right to buy)
11.36
2018-02-28
4
D
0
188800
12.64
D
2024-12-16
Common Stock
188800
0
D
Stock Option (right to buy)
18.26
2018-02-28
4
D
0
10000
5.74
D
2026-06-14
Common Stock
10000
0
D
Stock Option (right to buy)
13.38
2018-02-28
4
D
0
5000
10.62
D
2027-06-13
Common Stock
5000
0
D
Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share.
This option, which was fully vested on January 1, 2014, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
This option, which was fully vested on December 31, 2015, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
This option, which was fully vested on January 1, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
This option, which provided for vesting in 48 equal monthly installments commencing on December 1, 2014, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
This option, which provided for vesting in full on the earlier of June 14, 2017 and the date of the annual stockholder meeting following June 14, 2016, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
This option, which provided for vesting in full on the earlier of June 13, 2018 and the date of the annual stockholder meeting following June 13, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
/s/ Brent A. Moen, attorney-in-fact
2018-03-01